MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 228 filers reported holding MIRATI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $716,126 | +151.2% | 16,440 | +108.4% | 0.18% | +150.7% |
| Q2 2023 | $285,066 | +3.1% | 7,890 | +6.0% | 0.07% | +6.0% |
| Q1 2023 | $276,619 | +49.3% | 7,440 | +81.9% | 0.07% | +48.9% |
| Q4 2022 | $185,318 | -71.8% | 4,090 | -56.5% | 0.04% | -71.2% |
| Q3 2022 | $656,000 | -14.0% | 9,400 | -17.3% | 0.16% | -13.3% |
| Q2 2022 | $763,000 | +121.2% | 11,360 | +170.5% | 0.18% | +45.2% |
| Q1 2022 | $345,000 | -44.0% | 4,200 | 0.0% | 0.12% | -5.3% |
| Q4 2021 | $616,000 | -5.8% | 4,200 | +13.5% | 0.13% | -33.2% |
| Q3 2021 | $654,000 | +990.0% | 3,700 | +900.0% | 0.20% | +1052.9% |
| Q2 2021 | $60,000 | -89.5% | 370 | -88.9% | 0.02% | -91.2% |
| Q1 2021 | $572,000 | -22.1% | 3,340 | 0.0% | 0.19% | -17.8% |
| Q4 2020 | $734,000 | +36.9% | 3,340 | +3.4% | 0.24% | +44.8% |
| Q3 2020 | $536,000 | +21.3% | 3,230 | -43.8% | 0.16% | +1.2% |
| Q1 2020 | $442,000 | +59.6% | 5,750 | +167.4% | 0.16% | +46.4% |
| Q4 2019 | $277,000 | – | 2,150 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
| Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
| Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
| Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
| Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
| Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
| EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
| Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
| RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |